Skip to main content

Table 1 Summary of data arising from experiments utilizing 'omics' technologies.

From: Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms

Study
(Compartment)
I
(Plasma)
II
(Plasma)
III
(Plasma)
IV
(Plasma)
V
(Tissue)
VIa
(Tissue)
VIb
(Plasma)
VIIa
(Tissue)
VIIb
(Plasma)
Disease area Organ
Toxicity
Cardio-vascular
Disease
Infectious Disease Neuro-muscular Disease Organ Toxicity Organ Toxicity Organ Toxicity
Species Human Human Mouse Mouse Rat Rat Rat
Platforms
- GC/MS      
- Lipid LC/MS
- Polar LC/MS
- Proteomics
(Mass Spectrometry)
  
- Proteomics
(Multiplexed Immunoassay)
       
  1. The metabolomic platforms utilized in various studies include GC/MS (gas chromatography coupled with mass spectrometry), Lipid LC/MS (liquid chromatography coupled with mass spectrometry platform targeting lipids) and Polar LC/MS (liquid chromatography coupled with mass spectrometry platform targeting polar metabolites).